Literature DB >> 10359561

Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions.

F J Ghadessy1, J Lim, A A Abdullah, V Panet-Raymond, C K Choo, R Lumbroso, T G Tut, B Gottlieb, L Pinsky, M A Trifiro, E L Yong.   

Abstract

Structural changes in the androgen receptor (AR) are one of the causes of defective spermatogenesis. We screened the AR gene of 173 infertile men with impaired spermatogenesis and identified 3 of them, unrelated, who each had a single adenine-->guanine transition that changed codon 886 in exon 8 from methionine to valine. This mutation was significantly associated with the severely oligospermic phenotype and was not detected in 400 control AR alleles. Despite the location of this substitution in the ligand-binding domain (LBD) of the AR, neither the genital skin fibroblasts of the subjects nor transfected cell types expressing the mutant receptor had any androgen-binding abnormality. However, the mutant receptor had a consistently (approximately 50%) reduced capacity to transactivate each of 2 different androgen-inducible reporter genes in 3 different cell lines. Deficient transactivation correlated with reduced binding of mutant AR complexes to androgen response elements. Coexpression of AR domain fragments in mammalian and yeast two-hybrid studies suggests that the mutation disrupts interactions of the LBD with another LBD, with the NH2-terminal transactivation domain, and with the transcriptional intermediary factor TIF2. These data suggest that a functional element centered around M886 has a role, not for ligand binding, but for interdomain and coactivator interactions culminating in the formation of a normal transcription complex.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10359561      PMCID: PMC408364          DOI: 10.1172/JCI4289

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways.

Authors:  J J Voegel; M J Heine; M Tini; V Vivat; P Chambon; H Gronemeyer
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

2.  Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains.

Authors:  D M Tanenbaum; Y Wang; S P Williams; P B Sigler
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

3.  Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities.

Authors:  X F Ding; C M Anderson; H Ma; H Hong; R M Uht; P J Kushner; M R Stallcup
Journal:  Mol Endocrinol       Date:  1998-02

4.  The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors.

Authors:  S A Onate; V Boonyaratanakornkit; T E Spencer; S Y Tsai; M J Tsai; D P Edwards; B W O'Malley
Journal:  J Biol Chem       Date:  1998-05-15       Impact factor: 5.157

5.  Intermolecular NH2-/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity.

Authors:  E Langley; J A Kemppainen; E M Wilson
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

6.  Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).

Authors:  C A Berrevoets; P Doesburg; K Steketee; J Trapman; A O Brinkmann
Journal:  Mol Endocrinol       Date:  1998-08

7.  Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility.

Authors:  T G Tut; F J Ghadessy; M A Trifiro; L Pinsky; E L Yong
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

8.  Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators.

Authors:  T Ikonen; J J Palvimo; O A Jänne
Journal:  J Biol Chem       Date:  1997-11-21       Impact factor: 5.157

9.  Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.

Authors:  R T Nolte; G B Wisely; S Westin; J E Cobb; M H Lambert; R Kurokawa; M G Rosenfeld; T M Willson; C K Glass; M V Milburn
Journal:  Nature       Date:  1998-09-10       Impact factor: 49.962

10.  Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.

Authors:  S Westin; R Kurokawa; R T Nolte; G B Wisely; E M McInerney; D W Rose; M V Milburn; M G Rosenfeld; C K Glass
Journal:  Nature       Date:  1998-09-10       Impact factor: 49.962

View more
  10 in total

1.  Gain in transcriptional activity by primate-specific coevolution of melanoma antigen-A11 and its interaction site in androgen receptor.

Authors:  Qiang Liu; Shifeng Su; Amanda J Blackwelder; John T Minges; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

2.  Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions.

Authors:  C J Loy; K S Sim; E L Yong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

Review 3.  Structural features discriminate androgen receptor N/C terminal and coactivator interactions.

Authors:  Emily B Askew; John T Minges; Andrew T Hnat; Elizabeth M Wilson
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

Review 4.  Androgen receptor polymorphisms and mutations in male infertility.

Authors:  E L Yong; L S Lim; Q Wang; A Mifsud; J Lim; Y C Ong; K S Sim
Journal:  J Endocrinol Invest       Date:  2000-10       Impact factor: 4.256

5.  Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif.

Authors:  Katja Jehle; Laura Cato; Antje Neeb; Claudia Muhle-Goll; Nicole Jung; Emmanuel W Smith; Victor Buzon; Laia R Carbó; Eva Estébanez-Perpiñá; Katja Schmitz; Ljiljana Fruk; Burkhard Luy; Yu Chen; Marc B Cox; Stefan Bräse; Myles Brown; Andrew C B Cato
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

Review 6.  Androgens and spermatogenesis: lessons from transgenic mouse models.

Authors:  Guido Verhoeven; Ariane Willems; Evi Denolet; Johannes V Swinnen; Karel De Gendt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

7.  A natural polymorphism in peroxisome proliferator-activated receptor-alpha hinge region attenuates transcription due to defective release of nuclear receptor corepressor from chromatin.

Authors:  Mei Hui Liu; Jun Li; Ping Shen; B Husna; E Shyong Tai; E L Yong
Journal:  Mol Endocrinol       Date:  2008-02-21

Review 8.  Molecular mechanisms and cellular biology of the steroid receptor coactivator (SRC) family in steroid receptor function.

Authors:  Jianming Xu; Bert W O'Malley
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

9.  The consequences of mutations in the reproductive endocrine system.

Authors:  Donchan Choi
Journal:  Dev Reprod       Date:  2012-12

10.  Disorders of sex development: a genetic study of patients in a multidisciplinary clinic.

Authors:  Luigi Laino; Silvia Majore; Nicoletta Preziosi; Barbara Grammatico; Carmelilia De Bernardo; Salvatore Scommegna; Anna Maria Rapone; Giacinto Marrocco; Irene Bottillo; Paola Grammatico
Journal:  Endocr Connect       Date:  2014-09-23       Impact factor: 3.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.